Approval · Notice of Compliance 12069 · 2011
CELESTONE SOLUSPAN: Notice of Compliance 12069
Issued February 15, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12069
- Date
- February 15, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Injectable glucocorticoid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELESTONE SOLUSPAN | 00028096 | Marketed |
Medicinal ingredients
- BETAMETHASONE ACETATE 3 MG per ML
- BETAMETHASONE SODIUM PHOSPHATE 3 MG per ML